TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical Trial.

Tao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.